Imadul Islam,Srinivasan Thangathirupathy,Jayakumar Sankara Warrier,Srinivas Cheruku,Poornima Shetty,John E. Macor
申请号：
US15767385
公开号：
US20180312495A1
申请日:
2016.10.13
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present disclosure provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The Formula (I) compounds are ligands for NR2B N-Methyl-D-aspartate (NMD A) receptor and thereby making them useful for the treatment of various disorders of the central nervous system.
